Cargando…
What Underlies the Benefit of Famotidine Formulations Used During COVID-19?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the AGA Institute
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411504/ https://www.ncbi.nlm.nih.gov/pubmed/32777281 http://dx.doi.org/10.1053/j.gastro.2020.07.051 |
| _version_ | 1783568394765729792 |
|---|---|
| author | Singh, Vijay P. El-Kurdi, Bara Rood, Christopher |
| author_facet | Singh, Vijay P. El-Kurdi, Bara Rood, Christopher |
| author_sort | Singh, Vijay P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7411504 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | by the AGA Institute |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74115042020-08-07 What Underlies the Benefit of Famotidine Formulations Used During COVID-19? Singh, Vijay P. El-Kurdi, Bara Rood, Christopher Gastroenterology Correspondence by the AGA Institute 2021-04 2020-08-07 /pmc/articles/PMC7411504/ /pubmed/32777281 http://dx.doi.org/10.1053/j.gastro.2020.07.051 Text en © 2021 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Singh, Vijay P. El-Kurdi, Bara Rood, Christopher What Underlies the Benefit of Famotidine Formulations Used During COVID-19? |
| title | What Underlies the Benefit of Famotidine Formulations Used During COVID-19? |
| title_full | What Underlies the Benefit of Famotidine Formulations Used During COVID-19? |
| title_fullStr | What Underlies the Benefit of Famotidine Formulations Used During COVID-19? |
| title_full_unstemmed | What Underlies the Benefit of Famotidine Formulations Used During COVID-19? |
| title_short | What Underlies the Benefit of Famotidine Formulations Used During COVID-19? |
| title_sort | what underlies the benefit of famotidine formulations used during covid-19? |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411504/ https://www.ncbi.nlm.nih.gov/pubmed/32777281 http://dx.doi.org/10.1053/j.gastro.2020.07.051 |
| work_keys_str_mv | AT singhvijayp whatunderliesthebenefitoffamotidineformulationsusedduringcovid19 AT elkurdibara whatunderliesthebenefitoffamotidineformulationsusedduringcovid19 AT roodchristopher whatunderliesthebenefitoffamotidineformulationsusedduringcovid19 |